/ Not yet recruitingPhase 2 评价NWRD06在肝细胞癌根治术后患者中有效性和安全性的II期临床研究
[Translation] A Phase II clinical study evaluating the efficacy and safety of NWRD06 in patients after radical resection of hepatocellular carcinoma.
评价NWRD06在GPC3阳性肝细胞癌根治术后患者中的有效性和安全性
[Translation] Evaluate the efficacy and safety of NWRD06 in patients after radical resection of GPC3-positive hepatocellular carcinoma.
100 Clinical Results associated with Newish Technology (Taizhou) Co., Ltd.
0 Patents (Medical) associated with Newish Technology (Taizhou) Co., Ltd.
100 Deals associated with Newish Technology (Taizhou) Co., Ltd.
100 Translational Medicine associated with Newish Technology (Taizhou) Co., Ltd.